PubMed HealthSearch

Biomedical subjects

T Hraba

Publications and source records attributed to T Hraba.

At least 19 recordsLinked to original sources

Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity.

Lipid A preparations derived from the lipopolysaccharides of several gram-negative bacteria, as well as chemically defined synthetic lipid A's and their analogs (both glucosamine mono- and disaccharides), were used to establish the chemical structures required for (i) abolishing the expression of suppressor T cell (Ts) function and (ii) inducing polyclonal activation of B cells. Salmonella minnesota R595 lipid A (diphosphoryl lipid A) possesses both of these activities. Decreasing the number of phosphate groups in lipid A from two to one (monophosphoryl lipid A) as well as decreasing the fatty acyl content, primarily by removing the residue at the 3 position, resulted in a progressive reduction in toxicity; however, these structural modifications did not influence its ability to abolish the expression of Ts function. Reducing the fatty acyl content from five to four (lipid A precursor IVA or Ia) eliminated the capacity to influence Ts function but not to induce polyclonal activation of B cells. None of the monosaccharide analogs of lipid A examined influenced the expression of Ts activity, although some were able to activate B cells polyclonally. Thus, in order to be able to abolish the expression of Ts function, lipid A (i) must be a glucosamine disaccharide, (ii) may have either one or two phosphate groups, and (iii) must have at least five fatty acyl groups. Also, the chain length of the nonhydroxylated fatty acid, as well as the location of acyloxyacyl groups (2' versus 3' position), may play an important role. These findings indicate that the chemical structures responsible for the toxicity of lipid A differ from those that influence its capacity to abolish the expression of Ts function and to induce polyclonal activation of B cells.

Animals

Model-based analysis of CD4+ lymphocyte dynamics in HIV-infected individuals. II. Evaluation of the model based on clinical observations.

The recently developed mathematical model of CD4+ lymphocyte depletion in HIV-infected individuals is evaluated using a comparison with available clinical data. The data used for such an evaluation are to be extrapolated from the published clinical observations as these data sets are not homogeneous covering only parts of HIV infection duration. An additional complication is due to the uncertainty of exact infection onset. Based on these considerations, several different reference data sets are generated from the available clinical data and the range of applicability of the mathematical model and its modifications is then investigated. As a result of such quantitative confrontation, it can be concluded that the appropriate setting of cell interaction parameters in the model can result in a fairly good coincidence of the simulated HIV infection dynamics with reference data sets. Perspectives and limitations of such an approach are also discussed.

CD4-Positive T-Lymphocytes

Influence of the cell interaction parameters on the simulated CD4+ lymphocyte depletion in HIV infection.

The previously suggested mathematical models of CD4+ lymphocyte depletion in HIV-infected individuals are analysed from the point of view of fundamental cell interaction mechanisms involved. Under the assumption of growth restriction of the HIV by cytotoxic lymphocytes, the intensity of the feedback mechanism increasing the influx of immature CD4+ lymphocytes and the intensity of the helper effect of CD4+ lymphocytes during the maturation of cytotoxic cells are evaluated and compared in a wide range of the respective model parameters. In this respect also the role of the proliferation rate of these cytotoxic lymphocytes under antigenic stimulation by HIV products is discussed. In addition, an alternative elimination mechanism of CD4+ lymphocytes is investigated, which assumes their destruction by cytotoxic lymphocytes. It is concluded that any of the considered cases of the influx amplification parameter, helper effect intensity parameter, and CD4+ lymphocyte elimination mechanism can be used for a qualitative adjustment of the model to clinical data.

CD4-Positive T-Lymphocytes

Effect of a proline-rich polypeptide (PRP) on the development of hemolytic anemia and survival of New Zealand black (NZB) mice.

PRP, administered intraperitoneally into NZB mice, twice a week, at doses 0.01-1 microgram per mouse, significantly lowered the incidence of positive Coombs' reaction and prolonged the mean age of the mice. The effect of PRP on survival of mice was better when the treatment with PRP started early (in mice showing first signs of the disease). The results suggest that PRP may induce, from a precursor pool of cells, suppressor cells controlling development of the disease. In addition, the data indicate that PRP may have a therapeutical value in treatment of autoimmune disorders, e.g. the juvenile arthritis.

Anemia, Hemolytic, Autoimmune

Model-based analysis of CD4+ lymphocyte dynamics in HIV infected individuals.

The previously suggested mathematical model of CD4+ lymphocyte depletion in HIV-infected individuals is analyzed and further developed. The model assumes that CD4+ lymphocyte depletion is caused by HIV products. Fairly good simulation of CD4+ lymphocyte dynamics is obtained, when limitation of HIV growth by specific cytotoxic T cells is included in the model. As it is probable that the substantial decrease of CD4+ lymphocytes, this type of influx control mechanism is also included in the model. It is shown that the simulated CD4+ lymphocyte dynamics agree with the observed data, analogously as in the earlier considered case of the constant influx. Moreover, the depleting effect of HIV products on mature and/or immature CD4+ lymphocytes is analyzed by the model. Also, another modification of the model assuming that CD4+ lymphocyte depletion is due to their destruction by cytotoxic T cells specific for HIV antigens, gives simulation results comparable to those obtained by the original version of the model, where the mechanism of the depletion is not specified.

CD4-Positive T-Lymphocytes

Immunoregulatory effect of a synthetic peptide corresponding to a region of protein p24 of HIV.

The effect of a synthetic peptide, corresponding to a sequence of HIV-1 p24 protein (amino acids 218-237), on in vitro immune responses was studied. The peptide inhibited in a dose-dependent manner the induction of an anti-SRC antibody response and of a PPD-specific proliferative response of human PBL. On the other hand, PHA-induced proliferation of human PBL and PPD-induced proliferation of a PPD-specific human T-cell line were not modified by comparable amounts of the peptide. These results suggest that structures from a protein (p24), present in the serum throughout the course of HIV infection, are able to interfere with the inductive stages of specific immune responses. These findings may help to unravel some of the pathogenic mechanisms of AIDS and may contribute to the development of vaccine strategies.

Animals

Mathematical model of CD4+ lymphocyte depletion in HIV infection.

The CD4+ lymphocyte depletion in human immunodeficiency virus (HIV)-infected persons seems to be affected by HIV products. As the dynamics of the concentration of HIV products is reciprocal to that of non-replicating antigen used for induction of tolerance, the mathematical model of immunological tolerance can be used to describe the dynamics of CD4+ lymphocyte depletion. To stimulate the clinically observed dynamics, it is necessary to include the limitation of HIV growth by the corresponding cytotoxic T cells and their dependence on the helper effect of CD4+ lymphocytes. Simulation analysis suggests that qualitatively similar results are obtained if immature, mature, or both categories of CD4+ lymphocytes considered in the model are depleted by the HIV products.

Acquired Immunodeficiency Syndrome

Recovery from polyclonal tolerance: simulation analysis.

Mathematical model of immunological tolerance was applied to polyclonal B cell tolerance induced in mice by treatment with bacterial lipopolysaccharide (LPS) followed by the application of cyclophosphamide (CY). Satisfactory simulation results were obtained with the life-span of lymphocytes shorter than the experimentally observed one. It could be assumed that the massive decrease of lymphocyte population in polyclonal tolerance would elicit a compensatory reaction. Therefore it was postulated that some kind of feedback mechanism increased the influx of B lymphocytes. Having this factor included in the model, satisfactory agreement of the simulation results with experimental data was obtained for experimentally determined life-span of B cells.

Animals

Increase by bacterial lipopolysaccharide of antibody production in mice rendered hyporesponsive to lysozyme.

The effect of bacterial lipopolysaccharide (LPS) on the immune response of adult mice to hen egg lysozyme (HEL) was studied under conditions in which hyporesponsiveness to HEL was induced by: (i) the intravenous injection of syngeneic spleen cells incubated with HEL; (ii) the intravenous administration of soluble HEL, and (iii) the intraperitoneal injection of HEL in IFA. In all cases, mice were immunized by footpad injection of HEL, with or without LPS. The antibody response produced was measured by the number of indirect anti-HEL plaque forming cells (PFC) detected in popliteal lymph nodes. The incorporation of LPS in the immunizing dose of HEL had little effect on the response of controls; however, it resulted in an appreciable increase in the antibody response of all three groups of hyporesponsive mice. Although, after treatment with LPS, the number of PFC detected in mice made tolerant by spleen cell injection approached those of the controls, lower increases in the antibody response were noted for the remaining two groups of hyporesponsive mice.

Animals

Application of mathematical model of immunological tolerance to HIV infection.

Our experimental model of immunological tolerance to non-reproducing antigens is based on the assumption that tolerance is caused by elimination or irreversible inactivation of lymphocytes reacting specifically with the tolerance inducing antigen, and that recovery from tolerance is due to the spontaneous maturation from the stem cells of new lymphocytes reacting with the tolerated antigen. The recovery starts, when the antigen is eliminated from the organism and does not induce tolerance in newly arising lymphocytes any more. Here we report the application of this model to the depletion of CD4+ lymphocytes in persons infected with HIV. This depletion seems to be effected either directly or indirectly by HIV products. Therefore, the dynamics of this depletion can be described by the equations characterizing the dynamics of lymphocytes exposed to tolerance inducing antigen, when HIV products are substituted for antigen. In contrast to non-replicating antigens, the concentration of HIV products increases, as the infection progresses. In consequence, the CD4+ lymphocyte depletion increases with time and its dynamics are reciprocal to those of tolerance to non-reproducing antigens, which decrease with time.

Acquired Immunodeficiency Syndrome

A contribution to mathematical modelling of immunological tolerance.

The original simple mathematical model describing the kinetics of B cell tolerance was extended by the inclusion of Th cell tolerance. It anticipates the existence of two compartments of B and Th cells reactive to the antigen--the immature cells and the mature ones. It is assumed that tolerance is induced by irreversible inactivation of the antigen-reactive cells and the escape from tolerance is due to their differentiation from the precursors. There is also considered the situation, where two categories of Th cells cooperate with the same B cells. Besides that, suppressive activity on Th cells is included in the model. The simulated values are compared with experimental data.

Animals

Simulation analysis of the mechanism of escape from immunoglobulin suppression.

The mathematical model of B cell tolerance was applied to idiotype and isotype suppression of short duration induced in mice by neonatal application of monoclonal antibodies specific for the respective immunoglobulin determinants. Suppressor cells play an important role in chronic idiotype or isotype suppression, but these suppressions of short duration seem to be caused by direct elimination of B cells by the injected antibodies. The recovery from suppression of short duration starts, when the injected antibody is eliminated from the organism and is caused by differentiation from stem cells of new B lymphocytes possessing the respective immunoglobulin markers. This mechanism is analogous to that assumed for immunological tolerance in the mathematical model except that the injected monoclonal antibody plays the role of tolerance-inducing antigen. However, satisfactory agreement of simulated values with the experimental ones could not be obtained, if experimentally observed elimination rate of the injected antibody was used for calculations. A better fit was obtained with elimination rate values decreasing with age which do not correspond to the actual ones of the injected antibody. At present, we do not know which mechanism is described by these "virtual" elimination rates.

Animals

Implications of a mathematical model for the role of lymphocytes with different lifespans in the recovery from tolerance.

An extension of the mathematical model of immunological tolerance including two categories of B and T helper cells, each having a different lifespan, is presented. The simulated recovery from tolerance is compared with experimental data on B and T helper cell tolerance to human gamma globulin (HGG) induced in adult mice. The performed simulation runs suggest the conclusion that in this case it seems impossible to incorporate a high ratio of both, long-lived B cells and/or short-lived T helper cells, if good agreement with the available experimental data should be preserved.

Animals

The effect of bone marrow regulatory peptides on antibody production by hybridoma cells.

Peptides produced by bone marrow cells (myelopeptides) increase antibody production. Since antibody producing cells seemed to be their targets, we tested in these experiments the effect of myelopeptides on antibody production by 2B2 and 2C12 hybridoma cells. Both hybridomas produce anti-SRBC monoclonal antibodies of the IgM class. The 2B2 cells do not produce direct haemolytic plaques and less than 5% of them produce the indirect ones during the 90-min assay period. When they were cultivated with myelopeptides for 15 h, the number of indirect plaques increased two-fold. A slightly lower increase was observed after 24 h of incubation, while the 48-h incubation period did not increase the number of detected plaques. After 6 h of preincubation, only a slight increase in indirect plaque numbers was observed. About 25% of the 2C12 hybridoma cells produce both direct and indirect haemolytic plaques during the assay period. The effect of myelopeptides was studied only on the indirect ones and no clear effect was observed. Only after the 15-h incubation period a slight increase in plaque numbers was observed. Because the myelopeptides affect antibody production of hybridoma cells, antibody producing cells are evidently the targets of these substances. It remains to be established, whether they are the only target cells in the myelopeptide action on the immune response.

Animals

Effect of proline-rich polypeptide on experimental autoimmune response to erythrocytes.

PRP administration in parallel with RRBC injections increased the AEAP in mice, as did adult thymectomy carried out six weeks before the RRBC injections. On the other hand, PRP administration to thymectomized mice during immunization with RRBC decreased the intensity of AEAP to the level observed in intact, RRBC immunized controls. The number of ARFC among non-B lymphocytes in peripheral blood was increased in mice immunized with RRBC compared to those in non-immunized animals. PRP administration during immunization with RRBC or adult thymectomy lowered their number below the values in non-immune animals and non-B ARFC number comparable to those in control, immunized animals was observed in thymectomized mice injected with PRP in parallel with RRBC. The values of ARFC among the NAL were higher than among the non-B lymphocytes but their shifts in the individual experimental groups were in the same direction as among the non-B lymphocytes. However, their shifts after thymectomy and/or PRP treatment were in opposition to those of the intensity of AEAP in the respective experimental groups.

Animals

Two-chain disulphide-bonded structure of antigen-specific T-helper factor: both chains are necessary for activity and their interaction is I-A restricted.

The molecular structure of the antigen-specific T-helper factor (ThF) which augments contact sensitivity in mice was studied. ThF was split into two types of polypeptide chain by mild reduction and alkylation; one antigen binding (which determined the specificity), the other non-antigen binding. The two chains were, by themselves, inactive but complemented each other and reconstituted biological activity. In addition, a genetic restriction was observed in the complementation of the two chains which mapped to the I-A subregion of the H-2 complex.

Animals